Clinical Trials · NCT00259896
In-patient Study in Patients With Type 2 Diabetes Mellitus
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- GlaxoSmithKline
- Enrollment
- 30
- Start date
- Oct 2005
- Locations
- See registry
- Primary endpoint
- Pharmacodynamic measurements during 7 days of dosing.